Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
McKesson
Johnson and Johnson
Farmers Insurance
Medtronic
US Army
Chinese Patent Office
Julphar
Harvard Business School

Generated: January 22, 2018

DrugPatentWatch Database Preview

AZULFIDINE EN-TABS Drug Profile

« Back to Dashboard

Which patents cover Azulfidine En-tabs, and what generic alternatives are available?

Azulfidine En-tabs is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in AZULFIDINE EN-TABS is sulfasalazine. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Drug patent expirations by year for AZULFIDINE EN-TABS
Pharmacology for AZULFIDINE EN-TABS
Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Medical Subject Heading (MeSH) Categories for AZULFIDINE EN-TABS

US Patents and Regulatory Information for AZULFIDINE EN-TABS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073-002 Apr 6, 1983 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Novartis
Boehringer Ingelheim
UBS
Cantor Fitzgerald
Harvard Business School
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot